Ohr Pharmaceuticals (OHRP) Rating Lowered to Neutral at Roth Capital

Retrieved on: 2018-01-07 00:41:15

Tags for this article:

Click the tags to see associated articles and topics

Ohr Pharmaceuticals (OHRP) Rating Lowered to Neutral at Roth Capital. View article details on hiswai:

Excerpt

<div>Finally, <b>Vanguard Group</b> Inc. grew its stake in Ohr Pharmaceuticals by 0.7% in the second quarter. <b>Vanguard Group</b> Inc. now owns 812,418 shares of the biotechnology company's stock worth $520,000 after purchasing an additional 5,481 shares in the last quarter. 8.25% of the stock is currently owned ...</div>

Article found on:

View Original Article